Results 101 to 110 of about 8,484 (124)

Receptors and Signaling Pathways Controlling Beta-Cell Function and Survival as Targets for Anti-Diabetic Therapeutic Strategies. [PDF]

Cells
Dalle S, Abderrahmani A.
europepmc   +1 more source

Crosstalk between fat tissue and muscle, brain, liver, and heart in obesity: cellular and molecular perspectives. [PDF]

Eur J Med Res
Jia Z, Wang Z, Pan H, Zhang J, Wang Q, Zhou C, Liu J.   +6 more
europepmc   +1 more source

Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node. [PDF]

Cardiovasc Res
Lubberding AF, Veedfald S, Achter JS, Nissen SD, Soattin L, Sorrentino A, Vega ET, Linz B, Eggertsen CHE, Mulvey J, Toräng S, Larsen SA, Nissen A, Petersen LG, Bilir SE, Bentzen BH, Rosenkilde MM, Hartmann B, Lilleør TNB, Qazi S, Møller CH, Tfelt-Hansen J, Sattler SM, Jespersen T, Holst JJ, Lundby A.   +25 more
europepmc   +1 more source

Epinephrine, Pregabalin, and Crizotinib as Three Medicines with Polish Implications over Three Last Centuries and in View of Three Different Drug Discovery Approaches. [PDF]

Biomedicines
Kawczak P, Feszak I, Bączek T.
europepmc   +1 more source

Chronic stimulation desensitizes β2-adrenergic receptor responses in natural killer cells. [PDF]

Eur J Immunol
Jürgens M, Claus M, Wingert S, Niemann JA, Picard LK, Hennes E, Haasler I, Hellwig B, Overbeck N, Reinders J, Rahnenführer J, Schedel M, Capellino S, Watzl C.   +13 more
europepmc   +1 more source

Recent advances in the role of neuroregulation in skin wound healing. [PDF]

Burns Trauma
Al Mamun A, Shao C, Geng P, Wang S, Xiao J.   +4 more
europepmc   +1 more source

Competing signaling pathways controls electrotaxis. [PDF]

iScience
Kulkarni S, Tebar F, Rentero C, Zhao M, Sáez P.   +4 more
europepmc   +1 more source

Revisiting Pathogen Exploitation of Clathrin-Independent Endocytosis: Mechanisms and Implications. [PDF]

Cells
Goldmann O, Medina E.
europepmc   +1 more source

Incidence of alternative splicing associated with sex and opioid effects in the axon guidance pathway. [PDF]

Gene
Southey BR, Sunderland GR, Gomez AN, Bhamidi S, Rodriguez-Zas SL.   +4 more
europepmc   +1 more source

The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activity. [PDF]

Cell Commun Signal
Hmedat ANA, Doondeea J, Ebner D, Feller SM, Lewitzky M.   +4 more
europepmc   +1 more source